Table 2.
Comparison of parameters between patients with CKD5D and CKD ND.
| Parameter | CKD 5D (n = 165) | CKD ND (n = 48) | P Value |
|---|---|---|---|
| Age (years) | 50.5 (41,60) | 55 (45–62) | 0.157 |
| Sex | M-101 (61.2%) F-64 (38.8%) |
M−30 (62.5%) F-18 (37.5%) |
0.872 |
| Symptoms and Signs | |||
| Fever | 103 (62.4%) | 26 (54.2%) | 0.302 |
| Cough | 71 (43%) | 18 (37.5%) | 0.494 |
| Dyspnoea | 70 (42.4%) | 25 (52.1%) | 0.236 |
| Diarrhoea | 2 (1.2%) | 3 (6.3%) | 0.043∗ |
| Complications of COVID | |||
| Pneumonia | 71 (43%) | 17 (35.4%) | 0.346 |
| Encephalopathy | 21 (12.7%) | 4 (8.3%) | 0.405 |
| AKI | 12 (7.3%) | 19 (39.6%) | 0.00001∗ |
| Pancreatitis | 5 (3%) | 2 (4.2%) | 0.698 |
| Multisystemic Inflammatory Syndrome | 4 (2.4%) | 2 (4.2%) | 0.520 |
| Investigations | |||
| Hb (g/dL) | 7.7 (7,9) | 8.6 (7.4,10.7) | 0.01792 |
| Neutrophil/lymphocyte (N/L) ratio | 5 (3.3, 9.45) | 6.65 (3.3,14.1) | 0.3622 |
| Platelet Count (X105/mm³) | 1.47 (1.065,1.89) | 1.69 (1.195, 2.165) | 0.0853 |
| Outcomes | |||
| Total Days of admission | 13.5 (8.75, 18) | 12 (7.5,18.5) | 0.4671 |
| Days for RTPCR to turn negative | 15 (11,21.75) | 12.5 (8.25,15.5) | 0.04573∗ |
| Mortality | 37 (22.4%) | 12 (25%) | 0.709 |
CKD5D-Chronic Kidney Disease stage 5 on maintenance dialysis, CKDND-Chronic Kidney disease not on dialysis.